title: ISCHEMIA in chronic kidney disease: improving the representation of patients with chronic kidney disease in cardiovascular trials.
abstract: Despite the high cardiovascular risk associated with chronic kidney disease, a recent systematic review confirmed that patients with kidney disease remain underrepresented in cardiovascular trials. Two ongoing trials are assessing the risk:benefit of aggressive evaluation and intervention for ischemic heart disease in patients with advanced chronic kidney disease.
authors.affiliation: Department of Medicine, Division of Nephrology, Icahn School of Medicine at Mount Sinai, New York, New York, USA. Electronic address: christina.wyatt@mssm.edu.
authors.forename: Christina M
authors.initials: CM
authors.lastname: Wyatt
authors.affiliation: ISCHEMIA Clinical Coordinating Center, New York University School of Medicine, New York, New York, USA.
authors.forename: Matthew
authors.initials: M
authors.lastname: Shineski
authors.affiliation: Department of Medicine, Division of Nephrology, Stanford School of Medicine, Stanford, California, USA.
authors.forename: Glenn M
authors.initials: GM
authors.lastname: Chertow
authors.affiliation: Department of Medicine, Division of Cardiology, New York University School of Medicine, New York, New York, USA.
authors.forename: Sripal
authors.initials: S
authors.lastname: Bangalore
mesh_terms: D002318:Cardiovascular Diseases; D002908:Chronic Disease; D006801:Humans; D017202:Myocardial Ischemia; D051436:Renal Insufficiency, Chronic; D018570:Risk Assessment; D012307:Risk Factors